Table 3.

Summary statistics for duration (days) from randomisation to the last patient reported symptoms of nausea, vomiting, fever, defined as ≥38°C, and abdominal pain, for each treatment group (n, mean [SD], median [IQR] and min–max)

Group	N	Mean (SD)	Median (IQR)	Min–Max
Nausea
Control	13	2.1 (2.5)	1 (0–3)	0–8
Enterosgel	12	2.2 (2.4)	1 (1–4)	0–8
Vomiting
Control	4	0.8 (1.0)	1 (0–2)	0–2
Enterosgel	4	0.5 (0.6)	1 (0–1)	0–1
Fever
Control	21	3.8 (2.0)	4 (3–5)	0–7
Enterosgel	26	3.0 (2.6)	2 (1–5)	0–8
Abdominal pain
Control	9	0.2 (0.4)	0 (0–0)	0–1
Enterosgel	1	0.0 (0.0)	0 (0-0)	0